Gday NZ,
Makes sense. I possibly should have added that I think RAP was a poor deal for SH, just interested in the inner workings of the options.
Also, to be fair not really directly comparable given the number and value of options in play here. But interesting nonetheless.
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-699
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.010(4.65%) |
Mkt cap ! $81.16M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 21.5¢ | 20.5¢ | $113.4K | 540.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2623 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
20.5¢ |
Change
-0.010 ( 4.21 %) |
||||
| Open | High | Low | Volume | ||
| 21.0¢ | 21.5¢ | 20.5¢ | 318787 | ||
| Last updated 15.38pm 04/06/2024 ? | |||||
| PAA (ASX) Chart |